Taipei, Taiwan

Yu-Hong Cheng


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):

Title: Yu-Hong Cheng: Innovator in Glucagon-like Peptide Modulation

Introduction

Yu-Hong Cheng is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the development of treatments for hyperglycemia. His innovative work has led to the creation of novel compounds that have the potential to improve patient outcomes.

Latest Patents

Yu-Hong Cheng holds a patent for a "Glucagon-like peptide 1 modulator and uses thereof." This patent discloses novel glucagon-like peptide-1 (GLP-1) modulators and their applications in manufacturing medicaments for the treatment and/or prophylaxis of diseases and/or disorders associated with hyperglycemia. This advancement is crucial in the ongoing battle against diabetes and related conditions.

Career Highlights

Cheng is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at this institution has allowed him to collaborate with leading scientists and researchers in the field. His dedication to innovation and research has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Yu-Hong Cheng has worked alongside notable colleagues such as Rong-Jie Chein and Klim King. Their collaborative efforts have further enhanced the research and development of GLP-1 modulators, contributing to the advancement of medical science.

Conclusion

In summary, Yu-Hong Cheng is a distinguished inventor whose work in glucagon-like peptide modulation has the potential to transform the treatment of hyperglycemia. His contributions to Academia Sinica and collaborations with esteemed colleagues underscore his commitment to innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…